Physician profile
Mia E Layne
NPI 1417210931
$840.66
in general payments reported to CMS, 2019-2025
16 companies · $280 in 2025
The $280 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $160 · 2021: $135 · 2022: $53.42 · 2023: $212 · 2025: $280.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $492.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $491.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $259.07 | 2019-2023 | |
| Medtronic, INC. | $157.96 | 2023 | Interstim |
| Mayne Pharma Commercial LLC | $103.50 | 2025 | |
| Exeltis, USA INC. | $50.95 | 2023-2025 | Slynd |
| Millicent US INC | $42.60 | 2025 | Femlyv |
| Bayer Healthcare Pharmaceuticals INC. | $31.22 | 2025 | |
| Merck Sharp & Dohme LLC | $26.89 | 2019 | |
| Lupin INC. | $24.48 | 2021 | |
| Sumitomo Pharma America, INC. | $23.11 | 2025 | Myfembree |
| Hologic Sales and Service, LLC | $22.41 | 2025 | Novasure |
| Therapeuticsmd, INC. | $21.15 | 2021 | |
| Organon LLC | $19.50 | 2025 | Nexplanon |
| Allergan, INC. | $16.15 | 2019 | |
| Aspira Women'S Health INC | $15.89 | 2021 | |
| Avion Pharmaceuticals | $13.10 | 2021 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acessa Health INC. | $12.68 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mia Layne listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.